TY - JOUR
T1 - Pharmacovigilance in Herbal Drugs
T2 - A Challenge
AU - Sanghvi, Kemisha
AU - Subraya, Chandrashekar Kodangala
AU - Pai, Vasudev
AU - Nanjundaiah, Aswatha Ram Holavanna Halli
AU - Kunhikatta, Vijayanarayana
N1 - Funding Information:
The authors would like to acknowledge the facilities pro-vided by the Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education in executing this review article.
Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023/5
Y1 - 2023/5
N2 - There is a growing awareness of a disease at many levels, its treatment, and treatment outcomes including side effects. Alternative therapy techniques, herbal medicines and formulations are extensively acknowledged and practiced in India and around the world. Herbal medicine is usual-ly considered being safe regardless of the absence of scientific evidence to support its claims. Several issues concerning the methods in which herbal medications are labelled, evaluated, sourced, and used are connected to herbal medicine. Herbal therapeutics in the management and treatment of diabetes, rheumatism, hepatic disorders and other mild to chronic diseases and disorders are widely accepted. However, the adversities are difficult to recognize. The idea that the nature is safe and may be taken without the prescription of a physician has resulted in widespread self-medication across the world, sometimes with disappointing results, side effects, or unpleasant after-effects. The existing pharma-covigilance paradigm and its accompanying tools were created in connection with synthetic medi-cines. Nevertheless, adopting these approaches to keep records of herbal medications’ safety poses a distinct challenge. This might be due to the variations in the usage of non-traditional medicines, which can offer unique toxicological issues whether taken alone or in conjunction with other medica-tions. The goal of pharmacovigilance is to identify, analyse, explain, and minimize the adverse reac-tions and other drug-related complications associated with herbal, traditional, and complementary medications. Systematic pharmacovigilance is required to collect accurate data on the safety of herbal medications to create adequate guidelines for effective and safe usage.
AB - There is a growing awareness of a disease at many levels, its treatment, and treatment outcomes including side effects. Alternative therapy techniques, herbal medicines and formulations are extensively acknowledged and practiced in India and around the world. Herbal medicine is usual-ly considered being safe regardless of the absence of scientific evidence to support its claims. Several issues concerning the methods in which herbal medications are labelled, evaluated, sourced, and used are connected to herbal medicine. Herbal therapeutics in the management and treatment of diabetes, rheumatism, hepatic disorders and other mild to chronic diseases and disorders are widely accepted. However, the adversities are difficult to recognize. The idea that the nature is safe and may be taken without the prescription of a physician has resulted in widespread self-medication across the world, sometimes with disappointing results, side effects, or unpleasant after-effects. The existing pharma-covigilance paradigm and its accompanying tools were created in connection with synthetic medi-cines. Nevertheless, adopting these approaches to keep records of herbal medications’ safety poses a distinct challenge. This might be due to the variations in the usage of non-traditional medicines, which can offer unique toxicological issues whether taken alone or in conjunction with other medica-tions. The goal of pharmacovigilance is to identify, analyse, explain, and minimize the adverse reac-tions and other drug-related complications associated with herbal, traditional, and complementary medications. Systematic pharmacovigilance is required to collect accurate data on the safety of herbal medications to create adequate guidelines for effective and safe usage.
UR - http://www.scopus.com/inward/record.url?scp=85146558935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85146558935&partnerID=8YFLogxK
U2 - 10.2174/1574886317666220428125943
DO - 10.2174/1574886317666220428125943
M3 - Review article
AN - SCOPUS:85146558935
SN - 1574-8863
VL - 18
SP - 138
EP - 142
JO - Current Drug Safety
JF - Current Drug Safety
IS - 2
ER -